Clin2
NCT06989658Possibly a fitNot yet recruiting

Smart contact lens for Stargardt disease

Stargardt Disease

Part of Eyes & vision, Genetic & congenital clinical trials.

This study tests a new 'smart' contact lens that may help people with Stargardt disease see better. You will wear the lens for a short time so the team can check how well it works and how comfortable it feels.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
32 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old
  • You have been diagnosed with Stargardt disease (a rare inherited eye condition that causes vision loss)
  • Your eyesight in both eyes together is at least 20/400 — meaning you can see at 20 feet what a person with normal vision sees at 400 feet
  • You can wear a special large contact lens that sits on the white of the eye
  • You do not have other serious eye problems like severe dry eye, keratoconus, or a history of corneal infections

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06435000Recruiting
A study tracking Stargardt disease progression

This study follows people with Stargardt disease (a genetic eye condition that causes vision loss) over time. It aims to learn more about how the disease progresses and does not test any treatment.

San Diego, California
NCT06805474Recruiting
Study of a vision test for Stargardt and geographic atrophy

This study tests a new way to measure vision, called MLSDT, in people with normal sight or vision loss from Stargardt disease or geographic atrophy (a type of advanced age-related macular degeneration). Results will help doctors better understand how well patients can see.

Dallas, Texas
NCT06942572Recruiting· Phase 1/Phase 2
Gene therapy trial for Stargardt disease

This trial tests a new gene therapy called SB-007 for people with Stargardt disease (STGD1). It is given as an injection under the retina to see if it is safe and can help slow vision loss.

Aurora, Colorado
NCT07439887Recruiting· Phase 1/Phase 2
Study of an injection for Stargardt disease

This trial tests a single injection of a new medicine, RTx-021, into the eye for people with Stargardt disease. The goal is to see if it is safe and to find the right dose.

Bakersfield, California
NCT06375239Recruiting
Study of tests for tracking vision in retinal disease

This study will check if certain vision tests work well in people with retinal diseases like retinitis pigmentosa or Stargardt. Results will help design future trials.

Irvine, California
NCT07425574Recruiting
Study on how Stargardt eye conditions progress in children and adults

This study observes how Stargardt disease and similar eye conditions change over time in children and adults. It aims to learn more about the disease progression to help develop future treatments.

Phoenix, Arizona

Hear when a new Stargardt Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.